Visible vacuoles (origin) |
Yes (macropinosomes and endosomes) |
Yes (ER and mitochondria) |
Yes (ER and mitochondria) |
Yes (ER and mitochondria) |
No |
No |
No |
Yes (autophagosomes) |
Rupture of plasma membrane |
Yes |
Yes |
Yes |
Yes |
No |
Yes |
No |
Varies |
Cell swelling |
Yes |
Yes |
Yes |
Yes |
No |
Yes |
No |
No |
Membrane blebbing |
No |
Yes |
No |
No |
No |
No |
No |
No |
Chromatin condensation |
No |
Yes |
No |
Yes |
Yes |
Yes |
Yes |
Yes (late) |
DNA fragmentation |
Varies |
No |
No |
No |
No |
Yes |
Yes |
Yes (late) |
Activation of executioner caspases (occurs but not required) |
Yes |
No |
No |
No |
No |
No |
Yes |
Varies |
Accumulation of autophagosomes |
Yes |
|
Yes |
Yes |
No |
|
No |
Yes |
Mitochondrial membrane permeability |
|
Yes |
Yes |
Yes |
No |
No |
Yes |
Varies |
Lysosomal membrane permeability |
|
Yes |
No |
Yes |
No |
No |
|
Varies |
ATP depletion |
Yes |
Yes |
Yes |
Yes |
Yes |
No |
Yes |
Varies |
Inhibitors |
|
Glycine PARP inhibitors |
|
Necrostatin |
Ferrostatin iron chelators |
Caspase-1 inhibitors |
PARP inhibitors |
3-Methyl-adenine siRNA vs atg-5, beclin-1 |